Notice of AGM

Feedback

18/09/2025 13:07

RNS Number : 7811Z

Feedback PLC

18 September 2025

 

 

Feedback plc

 

Annual Report and Notice of Annual General Meeting

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that its Annual Report and Financial Statements for the year ended 31 May 2025, together with the Notice convening the Company's Annual General Meeting ("AGM"),  are now available on the Company's website at: https://feedbackmedical.com/investors. Hard copies of the 2025 Annual Report and Financial Statements and Notice of AGM have also been posted to shareholders today.

 

The AGM will be held at Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT, on Monday 13 October 2025 at 9:30 a.m.

 

AGM Broadcast

In addition to attending in person, shareholders will have the option to follow the proceedings of the AGM online. Shareholders interested in attending online are requested to register their remote attendance with Walbrook PR, the Company's Investor & Public Relations adviser, by emailing feedbackplc@walbrookpr.com.

 

This will be a closed forum and shareholders wishing to attend will be required to supply proof of their shareholding or a letter of corporate representation. Upon successful registration, a link will be emailed to attendees wishing to join online up to 48 hours before the AGM.

 

There will be no corporate presentation. Specific questions may be lodged by email to Walbrook PR at feedbackplc@walbrookpr.com and the Directors will endeavour to answer them during the question and answer part of the AGM. Shareholders will be able to view the business of the AGM only and will not be able to use this facility to vote, raise points or issues, ask questions or table resolutions.

 

-Ends-

 

Enquiries:

 

Feedback plc
Tom Oakley, CEO
Anesh Patel, CFO
+44 (0) 20 3997 7634
IR@fbk.com
Panmure Liberum Limited (NOMAD and Broker)
Emma Earl/ Mark Rogers (Corporate Finance)
Rupert Dearden (Corporate Broking)
+44 (0)20 7886 2500
Walbrook PR Ltd;
Tel: 020 7933 8780 orfeedbackplc@walbrookpr.com
Nick Rome/Joe Walker
07748 325 236 or 07407 020 470

 

About Feedback plc

 

Feedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

 

By linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

 

Bleepa® is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.

 

The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

 

https://feedbackmedical.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NOAVDLFFEKLFBBZ